Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Healthtrust
Queensland Health
Accenture
Fuji

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nitrendipine

« Back to Dashboard

US Patents for Nitrendipine

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nitrendipine ➤ Sign Up Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) ➤ Sign Up
Nitrendipine ➤ Sign Up Therapeutic approaches for treating Parkinson's disease Pharnext (Issy les Moulineaux, FR) ➤ Sign Up
Nitrendipine ➤ Sign Up Combination therapy Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) ➤ Sign Up
Nitrendipine ➤ Sign Up Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ➤ Sign Up
Nitrendipine ➤ Sign Up Synthetic linear apelin mimetics for the treatment of heart failure NOVARTIS AG (Basel, CH) ➤ Sign Up
Nitrendipine ➤ Sign Up Di- or tripeptide renin inhibitors containing lactam conformational restriction in Achpa Merck & Co., Inc. (Rahway, NJ) ➤ Sign Up
Nitrendipine ➤ Sign Up Di- or tripeptide renin inhibitors containing lactam conformational restriction in achpa Merck & Co., Inc. (Rahway, NJ) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Nitrendipine

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Nitrendipine World Intellectual Property Organization (WIPO) 2014052836 2032-09-27 ➤ Sign Up
Nitrendipine Australia 2012222348 2031-03-01 ➤ Sign Up
Nitrendipine Australia 2012222351 2031-03-01 ➤ Sign Up
Nitrendipine Australia 2013224959 2031-03-01 ➤ Sign Up
Nitrendipine Australia 2013224960 2031-03-01 ➤ Sign Up
Nitrendipine Australia 2014314055 2031-03-01 ➤ Sign Up
Nitrendipine Australia 2017210501 2031-03-01 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Chinese Patent Office
Cantor Fitzgerald
Colorcon
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: